UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 449

Sortiert nach

A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI‐0052‐107): final study results

British journal of haematology, 2018-01, Vol.180 (1), p.41-51

2018

Volltextzugriff (PDF)

Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results

Clinical cancer research, 2016-09, Vol.22 (18), p.4559-4566

2016

Volltextzugriff (PDF)

Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5474-5483

2005

Volltextzugriff (PDF)

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients

British journal of haematology, 2016-09, Vol.174 (5), p.711-720

2016

Volltextzugriff (PDF)

First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors

Investigational new drugs, 2017-06, Vol.35 (3), p.315-323

2017

Volltextzugriff (PDF)

A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF‐05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327‐01)

British journal of clinical pharmacology, 2014-12, Vol.78 (6), p.1281-1290

2014

Volltextzugriff (PDF)

Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors: Results From a Phase I Study

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5464-5473

2005

Volltextzugriff (PDF)

Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data

Neuro-oncology advances, 2021-01, Vol.3 (1), p.vdab142-vdab142

2021

Volltextzugriff (PDF)

Forging a Laboring Race: The African American Worker in the Progressive Imagination by Paul R. D. Lawrie

Labor: Studies in Working-Class History of the Americas, 2018-03, Vol.15 (1), p.112

Reich, Steven A

2018

Volltextzugriff (PDF)

A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer

Urologic oncology, 2013-07, Vol.31 (5), p.581-588

2013

Volltextzugriff (PDF)

Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin (NPI-2358) in Patients with Solid Tumors or Lymphomas

Clinical cancer research, 2010-12, Vol.16 (23), p.5892-5899

2010

Volltextzugriff (PDF)

Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors

Clinical cancer research, 2008-11, Vol.14 (22), p.7526-7534

2008

Volltextzugriff (PDF)

A case of myelopathy because of enchondromas from Maffucci syndrome with successful surgical treatment

The spine journal, 2015-06, Vol.15 (6), p.e15-e19

2015

Volltextzugriff (PDF)

Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial

Journal of the American Academy of Dermatology, 2003-11, Vol.49 (5), p.801-815

2003

Volltextzugriff (PDF)

Lumbar hemangioma masking a plasma cell tumor—case report and review of the literature

The spine journal, 2013-08, Vol.13 (8), p.e11-e15

2013

Volltextzugriff (PDF)

Evaluating imbalances of adverse events during biosimilar development

mAbs, 2016-07, Vol.8 (5), p.861-866

2016

Volltextzugriff (PDF)

Multi-Institutional Phase I/II Trial of Oral Bexarotene in Combination With Cisplatin and Vinorelbine in Previously Untreated Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2001-05, Vol.19 (10), p.2626-2637

2001

Volltextzugriff (PDF)

Splenic artery embolization: a single center experience on the safety, efﬁcacy, and clinical outcomes

Diagnostic and interventional radiology (Ankara, Turkey), 2013-01, Vol.19 (1), p.49-55

2013

Volltextzugriff (PDF)

The Great Migration and the Literary Imagination

The Journal of the Historical Society (Boston, Mass.), 2009-03, Vol.9 (1), p.87-128

Reich, Steven A.

2009

Volltextzugriff (PDF)

The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)

Leukemia research, 2006-07, Vol.30 (7), p.801-811

2006

Volltextzugriff (PDF)

The impact of short term synaptic depression and stochastic vesicle dynamics on neuronal variability

Journal of computational neuroscience, 2013-08, Vol.35 (1), p.39-53

2013

Volltextzugriff (PDF)

Multidisciplinary care considerations for gender nonconforming adolescents with eating disorders: A case series

The International journal of eating disorders, 2018-05, Vol.51 (5), p.475-479

2018

Volltextzugriff (PDF)

Class Groups of Characteristic-p Function Field Analogues of Q(n1/p)

Reich, Steven

2021

Volltextzugriff (PDF)

Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1

Blood, 2016-06, Vol.127 (22), p.2693-2700

2016

Volltextzugriff (PDF)

Assessing the Health Potential of Urban Green Space in an Urban Planning and Design Context: a Comparative Case Study in the City of Stockholm on Differences in Accessibility, Quality, and Inclusivity

Reich, Steven Lee Jonas

2022

Volltextzugriff (PDF)

1 – 25 von 449

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(386)
Mit Volltextzugriff
(409)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(248)
Life Sciences & Biomedicine
(204)
Humans
(183)
Female
(105)
Male
(97)
Middle Aged
(73)
Adult
(70)
Biological And Medical Sciences
(70)
Medical Sciences
(59)
Aged
(54)
Neurosciences & Neurology
(35)
Animals
(30)
Treatment Outcome
(27)
Neurosciences
(24)
Clinical Neurology
(23)
Oncology
(23)
Science & Technology - Other Topics
(22)
Magnetic Resonance Imaging
(21)
Multidisciplinary Sciences
(21)
Multiple Sclerosis
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI‐0052‐107): final study results

Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results

Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients

First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors

A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF‐05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327‐01)

Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors: Results From a Phase I Study

Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data

Forging a Laboring Race: The African American Worker in the Progressive Imagination by Paul R. D. Lawrie

A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer

Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin (NPI-2358) in Patients with Solid Tumors or Lymphomas

Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors

A case of myelopathy because of enchondromas from Maffucci syndrome with successful surgical treatment

Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial

Lumbar hemangioma masking a plasma cell tumor—case report and review of the literature

Evaluating imbalances of adverse events during biosimilar development

Multi-Institutional Phase I/II Trial of Oral Bexarotene in Combination With Cisplatin and Vinorelbine in Previously Untreated Patients With Advanced Non–Small-Cell Lung Cancer

Splenic artery embolization: a single center experience on the safety, efﬁcacy, and clinical outcomes

The Great Migration and the Literary Imagination

The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)

The impact of short term synaptic depression and stochastic vesicle dynamics on neuronal variability

Multidisciplinary care considerations for gender nonconforming adolescents with eating disorders: A case series

Class Groups of Characteristic-p Function Field Analogues of Q(n1/p)

Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1

Assessing the Health Potential of Urban Green Space in an Urban Planning and Design Context: a Comparative Case Study in the City of Stockholm on Differences in Accessibility, Quality, and Inclusivity

Suchergebnisse filtern